Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Achillion Pharmaceuticals, Inc. (ACHN) Starts Presentation at the Noble 8th Annual Equity Conference

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is a pharmaceutical company focused on bringing important new treatments to patients with infectious disease such as hepatitis C and resistant bacterial infections. The Company’s discovery and development teams have advanced several product candidates with novel mechanisms of action. For further information, visit the Company’s Web site at www.achillion.com.

Noble Financial, a research driven, full-service investment banking boutique, is as discriminating with its invitations to institutional investors as it is with the companies invited to present. Rather than just focusing on crowding the conference floor, Noble Financial carefully invites a smaller audience of investors with a large appetite for the companies presenting; quality always trumps quantity. For more information or to view webcasts of today’s presentations, visit www.noblefcm.com.

Let us hear your thoughts below:

This entry was posted in Noble Equity Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *